Loading...
Chemical structure of Adriblastin

GC10686

Adriblastin

Also listed as Epirubicin HCl

Epirubicin HCl (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase· Epirubicin HCl inhibits DNA and RNA synthesis· Epirubicin HCl is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity

ChemicalCAS56390-09-1MW579.98FormulaC27H29NO11·HCl
CAS number
56390-09-1
Molecular weight
579.98
Formula
C27H29NO11·HCl
Solubility
≥ 55·6 mg/mL in DMSO, ≥ 10·12 mg/mL in EtOH with ultrasonic and warming, ≥ 40·33 mg/mL in Water with gentle warming
InChIKey
MWWSFMDVAYGXBV-FGBJBKNOSA-N
Catalogue number
GC10686
Brand
GLPBIO
Computed properties PubChem CID 32874 · TPSA 206 Ų · H-bond donors 7 · H-bond acceptors 12
TPSA
206 Ų
H-bond donors
7
H-bond acceptors
12
Rotatable bonds
5
Heavy atoms
40

SMILES CC1C(C(CC(O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl

Computed descriptors from PubChem (CID 32874), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.